C4 Therapeutics, Inc.
Clinical trials sponsored by C4 Therapeutics, Inc., explained in plain language.
-
New hope for Hard-to-Treat myeloma: experimental combo enters phase 2
Disease control Recruiting nowThis study tests a new drug, cemsidomide, combined with dexamethasone in people with multiple myeloma that has returned or not responded to at least three prior treatments. About 100 adults will receive the drug combo to see if it shrinks tumors and how safe it is. The goal is to…
Phase: PHASE2 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug duo targets Hard-to-Treat myeloma in early trial
Disease control Recruiting nowThis early-phase study tests whether a new drug called cemsidomide, when combined with the existing drug elranatamab, is safe for people with multiple myeloma that has returned or stopped responding to prior treatments. About 60 participants will receive different doses of cemsid…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC